Do Transgender Youth Benefit from Gender-Affirming Hormones? Part II

Published February 15, 2023


[Part I, in which I critique the NEJM’s original research, is available here.]

Each edition of the New England Journal of Medicine includes at least one editorial on an original piece of research in that issue. These are authoritative critiques, written by leading experts invited by the Journal, meant to place the research in scientific context and point to any serious flaws. Dutch psychiatrist Annalou de Vries, the lead author of one such editorial from the January 19th, 2023, issue, is notable for being a member of the left-wing World Professional Association of Transgender Health (WPATH), where she serves on a committee for children and adolescents. De Vries also heads up the Center of Expertise on Gender Dysphoria, housed at Amsterdam University Medical Centers.

In short, de Vries is a longstanding proponent of various medical interventions for transgender youth. Yet even she points to significant problems with the NEJM’s new and widely cited study by Diane Chen et al.

Continue reading on Goldman’s Substack, “Side Effects”.

Devorah Goldman is EPPC’s Tikvah Visiting Fellow. Her work focuses primarily on medical policy, culture, and public bioethics.

Most Read

This field is for validation purposes and should be left unchanged.

Sign up to receive EPPC's biweekly e-newsletter of selected publications, news, and events.

Upcoming Event |

Roger Scruton: America


Your support impacts the debate on critical issues of public policy.

Donate today